On August 10, 2022, the U.S. Food and Drug Administration (FDA) announced the granting of standard approval to Tabrecta (carmatinib) for the treatment···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 86
The price of lenvatinib varies depending on the brand, strength, and region. Generally, the price ranges from 600 to 2000 yuan. The specific price may···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 89
The price of lenvatinib (generic name) varies depending on factors such as dosage, region, and medical insurance policies, typically fluctuating betwe···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 91
The price of lenvatinib (a multi-target anti-tumor drug) is affected by factors such as specifications, region, and medical insurance policies. In Chi···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 87
The latest price of lenvatinib (generic name: lenvatinib mesylate capsules) is affected by region, specification, purchase channel, and medical insura···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 92
The price of baricitinib is affected by factors such as dosage, region, and medical insurance policies. In China, the price per box typically ranges f···【Read More】
Update: 2026-03-26Source: Haiou HealthViews: 98
Larotrectinib, a precision-targeted therapy against NTRK gene fusions, requires individualized dosage and administration based on the patient's tu···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 92
The price of larotrectinib varies significantly depending on region, dosage, and medical insurance policies. In China, the price is typically between ···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 93
The price of larotrectinib varies significantly depending on region, dosage, health insurance policy, and purchase channel. According to publicly avai···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 101
The price of larotrectinib varies significantly depending on factors such as region, dosage, and health insurance policies. In China, the annual treat···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 92
The price of Adagrasib varies depending on region, strength, purchase channel, and health insurance policy. This is a prescription drug and must be us···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 91
Ivosidenib is a targeted therapy for IDH1 gene mutations, primarily used to treat relapsed or refractory acute myeloid leukemia (AML) and cholangiocar···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 91
Ivosidenib is a targeted therapy for specific gene mutations, primarily used to treat relapsed or refractory acute myeloid leukemia (AML) with IDH1 mu···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 91
The price of Ivosidenib is affected by factors such as dosage, region, and medical insurance policies. In China, the price per box typically ranges fr···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 101
Agios, a leading US-based cancer biopharmaceutical company and a pioneer in cellular metabolic therapies for cancer and rare genetic diseases, recentl···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 91
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



